Literature DB >> 23845590

EPAC expression and function in cardiac fibroblasts and myofibroblasts.

Ivonne Olmedo1, Claudia Muñoz, Nancy Guzmán, Mabel Catalán, Raúl Vivar, Pedro Ayala, Claudio Humeres, Pablo Aránguiz, Lorena García, Victoria Velarde, Guillermo Díaz-Araya.   

Abstract

UNLABELLED: In the heart, cardiac fibroblasts (CF) and cardiac myofibroblasts (CMF) are the main cells responsible for wound healing after cardiac insult. Exchange protein activated by cAMP (EPAC) is a downstream effector of cAMP, and it has been not completely studied on CF. Moreover, in CMF, which are the main cells responsible for cardiac healing, EPAC expression and function are unknown. We evaluated in both CF and CMF the effect of transforming growth factor β1 (TGF-β1) on EPAC-1 expression. We also studied the EPAC involvement on collagen synthesis, adhesion, migration and collagen gel contraction.
METHOD: Rat neonatal CF and CMF were treated with TGF-β1 at different times and concentrations. EPAC-1 protein levels and Rap1 activation were measured by western blot and pull down assay respectively. EPAC cellular functions were determined by adhesion, migration and collagen gel contraction assay; and collagen expression was determined by western blot.
RESULTS: TGF-β1 through Smad and JNK significantly reduced EPAC-1 expression in CF, while in CMF this cytokine increased EPAC-1 expression through ERK1/2, JNK, p38, AKT and Smad3. EPAC activation was able to induce higher Rap1-GTP levels in CMF than in CF. EPAC and PKA, both cAMP effectors, promoted CF and CMF adhesion on fibronectin, as well as CF migration; however, this effect was not observed in CMF. EPAC but not PKA activation mediated collagen gel contraction in CF, while in CMF both PKA and EPAC mediated collagen gel contraction. Finally, the EPAC and PKA activation reduced collagen synthesis in CF and CMF.
CONCLUSION: TGF-β1 differentially regulates the expression of EPAC in CF and CMF; and EPAC regulates differentially CF and CMF functions associated with cardiac remodeling.
© 2013.

Entities:  

Keywords:  Adhesion; Cardiac fibroblast and myofibroblast; Collagen; EPAC-1; Migration; TGF-beta1

Mesh:

Substances:

Year:  2013        PMID: 23845590     DOI: 10.1016/j.taap.2013.06.022

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP-signaling modules in T cells.

Authors:  Michael-Claude G Beltejar; Ho-Tak Lau; Martin G Golkowski; Shao-En Ong; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

Review 2.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

3.  Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling.

Authors:  Sirirat Surinkaew; Mona Aflaki; Abhijit Takawale; Yu Chen; Xiao-Yan Qi; Marc-Antoine Gillis; Yan-Fen Shi; Jean-Claude Tardif; Nipon Chattipakorn; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

4.  Stimulation of Adenosine A2B Receptor Inhibits Endothelin-1-Induced Cardiac Fibroblast Proliferation and α-Smooth Muscle Actin Synthesis Through the cAMP/Epac/PI3K/Akt-Signaling Pathway.

Authors:  Sarawuth Phosri; Ajaree Arieyawong; Kwanchai Bunrukchai; Warisara Parichatikanond; Akiyuki Nishimura; Motohiro Nishida; Supachoke Mangmool
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

5.  Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade.

Authors:  Stephanie D Burr; James A Stewart
Journal:  Cells       Date:  2021-05-22       Impact factor: 6.600

Review 6.  Roles of PDE1 in Pathological Cardiac Remodeling and Dysfunction.

Authors:  Si Chen; Walter E Knight; Chen Yan
Journal:  J Cardiovasc Dev Dis       Date:  2018-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.